A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P190
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Albershardt, Tina C
Parsons, Andrea J
Flynn, Patrick
Berglund, Peter
ter Meulen, Jan
Article History
First Online: 6 November 2014